Trademark: 79362319
Word
RECEPTKINE
Status Date
Tuesday, May 7, 2024
Registration Number
7376585
Registration Date
Tuesday, May 7, 2024
Filing Date
Thursday, January 12, 2023
Published for Opposition
Tuesday, February 20, 2024
5 Pharmaceutical preparations for immunity adjustment; Antibodies for veterinary purposes; Chemico-pharmaceutical preparations for use in the treatment of cancer, immune system related diseases and disorders; Albuminous preparations for medical purposes; Drugs for medical purposes, namely, for use in the treatment of cancer, immune system related diseases and disorders; Colostral antibodies for medical purposes; Antibody reagents for medical purposes for use in the treatment of cancer; Blood for medical purposes; Enzymes for medical purposes; Pharmaceutical drugs for use in the treatment of cancer, immune system related diseases and disorders; Human immune globulin; Medicines for human purposes, namely, for use in the treatment of cancer, immune system related diseases and disorders; Human plasma protein being blood plasma; Pharmaceutical preparations for use in the treatment of cancer, immune system related diseases and disorders; Haematogen, namely, blood substitutes for human use; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Antivirals; Antigens for use in the treatment of cancer; Antibody reagents used for the detection of the antigens in cells and tissue for medical purposes; Pharmaceutical preparations for use in hematology
42 Laboratory services relating to the production of monoclonal antibodies; Research and development of vaccines and medicines; Consultancy in the field of biotechnology; Research and development of technology for biotechnology; Scientific research in the field of biomedicine; Biological research; Biochemical research; Providing information relating to scientific research in the fields of biochemistry and biotechnology; Drug discovery services; Development of pharmaceutical preparations and medicines; Testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; Scientific research in the field of pharmacy; Scientific research in the field of genetic engineering; Medicine research; Laboratory research services relating to pharmaceuticals; Medical and pharmacological research services; Medical research; Medical and pharmacological research, namely, clinical trials for others; Blood analysis services for scientific research purposes; Chemical engineering
Feb 9, 2023
Sn Assigned For Sect 66a Appl From Ib
Feb 11, 2023
New Application Office Supplied Data Entered
Feb 15, 2023
Application Filing Receipt Mailed
Oct 10, 2023
Assigned To Examiner
Oct 11, 2023
Non-Final Action Written
Oct 12, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Oct 24, 2023
Refusal Processed By Mpu
Oct 24, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Nov 13, 2023
Refusal Processed By Ib
Jan 14, 2024
Teas Change Of Domestic Representatives Address
Jan 14, 2024
Teas Change Of Owner Address Received
Jan 14, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 14, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 14, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 14, 2024
Teas Change Of Correspondence Received
Jan 16, 2024
Teas Response To Office Action Received
Jan 16, 2024
Correspondence Received In Law Office
Jan 17, 2024
Teas/Email Correspondence Entered
Jan 18, 2024
Approved For Pub - Principal Register
Jan 31, 2024
Notification Of Notice Of Publication E-Mailed
Jan 31, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 7, 2024
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 7, 2024
Notification Of Possible Opposition Sent To Ib
Feb 20, 2024
Published For Opposition
Feb 27, 2024
Notification Processed By Ib
May 7, 2024
Notice Of Registration Confirmation Emailed
Aug 7, 2024
Final Disposition Notice Created, To Be Sent To Ib
May 7, 2024
Registered-Principal Register
Mar 4, 2024
Official Gazette Publication Confirmation E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
